Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 for Depression and Other Cardiac Risk Factors
NCT00116857Phase 3Completed
- Sponsor
- Washington University School of Medicine
- Start
- Feb 2005
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of omega-3-acid triglycerides in major depressive disorder (MDD) (2 arms), sponsored by Washington University School of Medicine. Primary endpoint: Beck Depression Inventory-II at 10 weeks. Started Feb 2005; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00116857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00116857.